Compare ABR & ATEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ABR | ATEC |
|---|---|---|
| Founded | 2003 | 1990 |
| Country | United States | United States |
| Employees | 653 | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | N/A | 2006 |
| Metric | ABR | ATEC |
|---|---|---|
| Price | $5.40 | $9.30 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 5 | 11 |
| Target Price | $9.90 | ★ $22.00 |
| AVG Volume (30 Days) | ★ 3.8M | 2.9M |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | ★ 15.42% | N/A |
| EPS Growth | N/A | ★ 15.04 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $101,739,000.00 |
| Revenue This Year | N/A | $18.97 |
| Revenue Next Year | N/A | $16.70 |
| P/E Ratio | $9.29 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $4.99 | $6.82 |
| 52 Week High | $12.58 | $23.29 |
| Indicator | ABR | ATEC |
|---|---|---|
| Relative Strength Index (RSI) | 43.93 | 61.46 |
| Support Level | $4.99 | $7.05 |
| Resistance Level | $7.91 | $13.08 |
| Average True Range (ATR) | 0.19 | 0.45 |
| MACD | 0.08 | 0.15 |
| Stochastic Oscillator | 65.81 | 94.49 |
Arbor Realty Trust Inc is a specialized real estate finance company. It invests in a diversified portfolio of structured finance assets in the multifamily, SFR, and commercial real estate markets, consisting of bridge and mezzanine loans, including junior participating interests in first mortgages, preferred, and direct equity. In addition, it may also directly acquire real property and invest in real estate-related notes and certain mortgage-related securities. The company has two business segments, Structured Business and Agency Business. It generates a majority of its revenue from the Structured Business Segment.
Alphatec Holdings Inc is a medical technology company focused on the designing, development, and advancement of products for the surgical treatment of spinal disorders associated with disease and degeneration, congenital deformities, and trauma. The company's spine approach technologies include Posterior Cervical Fusion, Anterior Cervical Discectomy and Fusion, Lateral Interbody Fusion, and Posterior Lumbar Interbody Fusion among others. Its procedural offerings are designed to address the underlying causes of spinal pathology by advancing the three fundamental objectives of spine surgery: (1) decompression of neural elements, (2) stabilization of spinal segments, and (3) restoration and maintenance of proper spinal alignment.